News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syntiron LLC Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant under the U.S. Patient Protection and Affordable Care Act of 2010



11/12/2010 8:39:15 AM

SAINT PAUL, Minn.--(BUSINESS WIRE)--Syntiron, LLC, a private biotech company located in St. Paul, Minnesota, today announced the company was awarded a U.S. government grant under the Qualifying Therapeutic Discovery Project (QTDP) Program. Syntiron received the grant of $244,479 in support of its Bacterial Vaccine and Therapeutic Platform Technology, which includes the development of vaccines to prevent infections by Yersinia, Salmonella and Staphylococcus bacteria.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES